|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBOOKCENTRAL_ocn923276351 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
151010s2007 dcu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d MERUC
|d OCLCQ
|d ZCU
|d U3W
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d ICG
|d OCLCQ
|d DKC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9780309663458
|
| 020 |
|
|
|a 0309663458
|
| 029 |
1 |
|
|a DEBBG
|b BV044108610
|
| 029 |
1 |
|
|a DEBSZ
|b 452573149
|
| 035 |
|
|
|a (OCoLC)923276351
|
| 050 |
|
4 |
|a RA643.8.P75 2007eb
|
| 082 |
0 |
4 |
|a 614.5
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Countries, Committee on the Prevention of HIV Infection among Injecting Drug Users in High-Risk.
|
| 245 |
1 |
0 |
|a Preventing HIV Infection Among Injecting Drug Users in High Risk Countries :
|b an Assessment of the Evidence.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 2007.
|
| 300 |
|
|
|a 1 online resource (299 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a FrontMatter -- Reviewers -- Acknowledgments -- Contents -- Acronyms and Abbreviations -- Summary -- Introduction -- 1 HIV/AIDS in Injecting Drug Users -- 2 Treatment for Drug Dependence -- 3 Sterile Needle and Syringe Access, and Outreach and Education -- 4 Taking Action -- Appendixes -- Appendix A Agenda for Information-Gathering Meeting, Geneva, December 2005 -- Appendix B Literature Search Strategies -- Appendix C Country Case Examples
|
| 505 |
8 |
|
|a Appendix D Tables Summarizing the Evidence on Multi-Component HIV Prevention Programs That Include Needle and Syringe Exchange (NSE)Appendix E Additional Thoughts on a Community Randomized Trial of Multi-Component HIV Prevention Programs -- Appendix F Biographies
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a AIDS (Disease)
|
| 650 |
|
0 |
|a HIV infections
|x Prevention.
|
| 650 |
|
0 |
|a Intravenous drug abuse.
|
| 650 |
|
0 |
|a Needle exchange programs.
|
| 650 |
|
2 |
|a Acquired Immunodeficiency Syndrome
|
| 650 |
|
2 |
|a Substance Abuse, Intravenous
|
| 650 |
|
2 |
|a Needle-Exchange Programs
|
| 650 |
|
6 |
|a Sida.
|
| 650 |
|
6 |
|a Infections à VIH
|x Prévention.
|
| 650 |
|
6 |
|a Toxicomanie par voie veineuse.
|
| 650 |
|
6 |
|a Échange de seringues.
|
| 650 |
|
7 |
|a AIDS (Disease)
|2 fast
|
| 650 |
|
7 |
|a HIV infections
|x Prevention
|2 fast
|
| 650 |
|
7 |
|a Intravenous drug abuse
|2 fast
|
| 650 |
|
7 |
|a Needle exchange programs
|2 fast
|
| 776 |
0 |
8 |
|i Print version:
|a Countries, Committee on the Prevention of HIV Infection among Injecting Drug Users in High-Risk.
|t Preventing HIV Infection Among Injecting Drug Users in High Risk Countries : An Assessment of the Evidence.
|d Washington : National Academies Press, ©1900
|z 9780309102803
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378165
|z Texto completo
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3378165
|
| 994 |
|
|
|a 92
|b IZTAP
|
